Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518594 | SCV000614557 | benign | not specified | 2016-12-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001851449 | SCV002107270 | uncertain significance | not provided | 2024-02-06 | criteria provided, single submitter | clinical testing | In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge |
Ce |
RCV001851449 | SCV004142825 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | PKD1: BP4, BP7 |
Genetic Services Laboratory, |
RCV000518594 | SCV003839851 | likely benign | not specified | 2022-05-27 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003942699 | SCV004766446 | likely benign | PKD1-related disorder | 2019-12-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |